Changes in Thyroid Functional Tests in Breast Cancer Patients under Tamoxifen Therapy

HR Mirzaei--- ,
A Rakhsha--- ,
A Fazlallizadeh--- ,
B Mofid--- ,
M Hoshiari---

Abstract


155

Abstract

Background: Tamoxifen, a synthetic anti-estrogen agent, is administered as an

adjuvant treatment in breast cancer. Since various studies have indicated that

Tamoxifen can change some hormones and bound globolines, controversial results

have been achieved using this medicine on Thyroid Functional Tests (TFT). The present

study was conducted to investigate the effects of Tamoxifen on TFT in women with

breast cancer referred to oncology clinic in Imam Hossein hospital between 2001

and 2002.

Method: A quasi-experimental clinical trial study was performed on 23 women with

breast cancer in a single blind basis (with no control group). Patients were under

Tamoxifen 20 mg P.O. daily and their serum TSH, free T4 and three Iodothyronine

(T3) were assessed before treatment with Tamoxifen and after 3 months. Paired T

test was used for statistical analysis.

Results: There was a significant difference in T3 before and after the treatment with

Tamoxifen (p=0.02), whereas no significant differences were seen in TSH (p=0.095)

and FT4 (p=0.13).

Discussion: This study showed that treatment with Tamoxifen in women suffering

from breast cancer results in an increase in serum T3 but has no effect on serum TSH

and FT4, therefore women under treatment with Tamoxifen remain euthyroid.

Keywords: thyroid function tests, breast cancer, tamoxifen

1. Perez C, Brady L. Principles and of Radiation oncology, 3rd  edition, Lippincott- Raven.2005: 1420-22

 

2. Devita V, Helman J. Principle and practice of oncology, 6th edition vol 2, Lippincott, Williams & Wilkins, 2006: 1443-44

 

3. Haskell C: Cancer Treatment, 5th  edition, Saunders, 2001: 199-202

 

4. Momby C, Love R, et al. Thyroid function test changes with adjuvant Tamoxifen therapy in postmenopausal women with breast cancer. J of Clinical Oncology. 1995; 13(4): 854-7

 

5. Zidan J, et al. Effect of adjuvant Tamoxifen therapy on thyroid function in postmenopausal women with breast cancer. Oncology., 1999;56 (1): 43-5

 

6. Sinard R, et al.Hypothyroidism after treatment ror non thyroidal head and neck cancer. Arch. Otolaryngology Head and Neck Surgery. 2000; 126 (5): 625-7

 

7. Tell R, et al. Hypothyroidism after external radiotherapy for head and neck cancer. Int J Radiat Oncology boil. Phy. 1997; 39 (2): 303-8

 

8. Bruning P, et al. Primary hypothyroidism in breast cancer patients with irradiated supraclavicular Iymph node. Br J Cancer.1985; 51: 659-63

 

9. Vilkari J, et al. Thyroid function postoperative radiation therapy in patients with breast cancer. Acta Radiol Oncol. 1988; 25: 167-70

 


Full Text:

PDF

141